Skip to contentC
CareDx, Inc.
C
CDNACareDx, Inc. Q2 2026 · 10-Q
Revenue$131.95M$131.95M+52.2% vs Q2 2025 Net Income$110.64M$110.64MN/M vs Q2 2025 EPS Diluted$2.07$2.07N/M vs Q2 2025 Operating Income$113,223,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CareDx, Inc. · CIK 1217234 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$28,746,000+223.4% Margins · derivedOperating margin85.8%+98.6 pt vs Q2 2025
Net margin83.8%+93.7 pt vs Q2 2025
ended Jun 30, 2026 · filed Jul 30, 2026 · 30 d after period end